Original Research
Published on 12 Jan 2022
Piperlongumine Is an NLRP3 Inhibitor With Anti-inflammatory Activity
in Inflammation Pharmacology
- 5,077 views
- 16 citations
Original Research
Published on 12 Jan 2022
in Inflammation Pharmacology
Review
Published on 12 Jan 2022
in Inflammation Pharmacology
Mini Review
Published on 10 Jan 2022
in Inflammation Pharmacology
Original Research
Published on 10 Jan 2022
in Inflammation Pharmacology
Correction
Published on 10 Jan 2022
in Inflammation Pharmacology
Original Research
Published on 07 Jan 2022
in Inflammation Pharmacology
Mini Review
Published on 07 Jan 2022
in Inflammation Pharmacology
Original Research
Published on 07 Jan 2022
in Inflammation Pharmacology
Original Research
Published on 05 Jan 2022
in Inflammation Pharmacology
Original Research
Published on 04 Jan 2022
in Inflammation Pharmacology
Brief Research Report
Published on 04 Jan 2022
in Inflammation Pharmacology
Original Research
Published on 03 Jan 2022
in Inflammation Pharmacology
Original Research
Published on 03 Jan 2022
in Inflammation Pharmacology
Original Research
Published on 03 Jan 2022
in Inflammation Pharmacology
Original Research
Published on 03 Jan 2022
in Inflammation Pharmacology
Original Research
Published on 24 Dec 2021
in Inflammation Pharmacology